Mark B. Irland, M.D. v. Iowa Board of Medicine

CourtCourt of Appeals of Iowa
DecidedMarch 6, 2019
Docket18-0353
StatusPublished

This text of Mark B. Irland, M.D. v. Iowa Board of Medicine (Mark B. Irland, M.D. v. Iowa Board of Medicine) is published on Counsel Stack Legal Research, covering Court of Appeals of Iowa primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mark B. Irland, M.D. v. Iowa Board of Medicine, (iowactapp 2019).

Opinion

IN THE COURT OF APPEALS OF IOWA

No. 18-0353 Filed March 6, 2019

MARK B. IRLAND, M.D., Plaintiff-Appellant,

vs.

IOWA BOARD OF MEDICINE, Defendant-Appellee. ________________________________________________________________

Appeal from the Iowa District Court for Polk County, Arthur E. Gamble,

Judge.

Mark Irland, M.D., appeals from the dismissal of his petition for judicial

review. AFFIRMED.

David L. Brown and Tyler R. Smith of Hansen, McClintock & Riley, Des

Moines, for appellant.

Thomas J. Miller, Attorney General, and Jordan G. Esbrook, Assistant

Attorney General, for appellee.

Heard by Vogel, C.J., Vaitheswaran, J., and Danilson, S.J.*

*Senior judge assigned by order pursuant to Iowa Code section 602.9206 (2019).

Gamble, S.J., takes no part. 2

DANILSON, Senior Judge.

Mark Irland, M.D., appeals from the dismissal of his petition for judicial

review, contending the district court erred in concluding it was without authority to

review the Confidential Letter of Warning issued to him by the Iowa Board of

Medicine. Finding no error, we affirm.

I. Background Facts and Proceedings.

Irland received a “Confidential Letter of Warning” from the Board indicating

its “serious concerns” with respect to his treatment of a patient. After detailing its

concerns regarding such treatment and noting the revocation of Irland’s clinical

privileges at a particular hospital, the Board’s letter stated, in pertinent part:

The Board advises that you carefully review your treatment of [the patient] and take appropriate steps to avoid similar concerns in the future. The Board also advises that you submit a paper to the Board describing what you have learned from this matter. Please submit the paper to [the Board’s legal director, at a specified address] within sixty (60) days . . . . The Board also noted that you are not practicing medicine at this time. Therefore, the Board has chosen not to initiate further action in this matter at this time. However, the Board advises that you provide it written notice at least sixty (60) days prior to returning to the practice of medicine. If you choose to return to the practice of medicine, the Board will take appropriate action, including but not limited to, issuing an order requiring you to complete a comprehensive clinical competency evaluation, to ensure that you are able to practice medicine with reasonable skill and safety. . . . Pursuant to Iowa Code chapter 272C, this CONFIDENTIAL LETTER OF WARNING does not constitute a formal disciplinary action, nor is it a public record. It is a private communication between you and the Board . . . . This CONFIDENTIAL LETTER OF WARNING concludes the Board’s investigation of this case. The Board reserves the right to review and reconsider this matter should it be deemed appropriate.

Irland filed a petition for judicial review of the Board’s letter of warning. The

Board filed a motion to dismiss pursuant to Iowa Code section 272C.3(1)(d) (2017), 3

which provides: “Notwithstanding the provisions of [Iowa Code chapter] 17A, a

determination by a licensing board . . . that an investigation should be closed

without initiating a disciplinary proceeding is not subject to judicial review pursuant

to section 17A.19(4).”

The district court concluded:

Pursuant to Iowa Code section 272C.3(1)(d), the Confidential Letter of Warning issued by the Board to Dr. Irland is not subject to judicial review. The advisory and warning language contained in the Confidential Letter of Warning are not disciplinary sanctions and do not transform the Confidential Letter of Warning into a final agency action that is subject to judicial review under Iowa Code section 17A.19. Further, the Confidential Letter of Warning is not a preliminary, procedural, or intermediate agency action that is immediately reviewable under Iowa Code section 17A.19(1). If Dr. Irland resumes his medical practice and if, as the Board warns in the letter, the Board issues an order requiring him to complete a comprehensive clinical evaluation, to ensure he is able to practice medicine with reasonable skill and safety, Dr. Irland may exhaust administrative remedies within the Board at that time. If a disciplinary proceeding is initiated by the Board against Dr. Irland, judicial review of a final agency action would provide an adequate remedy. See Iowa Code [§] 17A.19(1). However, since none of that has happened at this stage of the proceeding, judicial review is premature. All we have at this stage of the process is a Confidential Letter of Warning which by statute is not subject to judicial review. The court lacks authority to hear this particular case at this particular time. See Alliant Energy-Interstate Power and Light Co. v. Duckett, 732 N.W.2d 869, 874-75 (Iowa 2007).

Irland appeals.

II. Scope and Standard of Review.

We review the district court’s ruling on a motion to dismiss for the correction

of errors at law. Strickland v. Iowa Bd. of Med., 764 N.W.2d 559, 561 (Iowa Ct.

App. 2009). We apply the standards found in Iowa Code chapter 17A to determine 4

whether our conclusions are the same as those made by the district court. Doe v.

Iowa Bd. of Med. Exam’rs, 733 N.W.2d 705, 707 (Iowa 2007).

III. Discussion.

Pursuant to Iowa Code section 272C.3, the Iowa Board of Medicine is

authorized to investigate complaints against licensees and issue licensee

discipline. Under the board’s rules governing its investigations, the board is to

open a complaint file upon receipt of “appropriate information.” Iowa Admin. Code

r. 653-24.2(1). If the board determines it has jurisdiction of the complaint file, the

complaint is sent to a complaint review committee. Id. r. 653-24.2(1)(a). The

complaint review committee reviews the complaint and is authorized to take one

of the following actions: (1) close the complaint file for specified reasons, (2)

recommend the board’s screening committee close the file without investigation;

(3) “[r]equest an investigation by seeking a letter of explanation from the physician,

medical records, or both”; or (4) request a “full investigation.” Id. r. 653-24.2(2)(b).

Guidelines for the complaint review committee are set out in rule 653-24.2(2)(c).

The board’s screening committee reviews the recommendation of the

complaint review committee and takes one of four actions: (1) recommend the

board close the complaint file without investigation; (2) request an investigation;

(3) upon review of the materials received from its requests from the physician or

medical records, recommend the investigative file be closed, “with or without

issuing an informal letter”; or (4) request a full investigation for board review. Id. r.

653-24.2(3).

Investigations are governed by rule 653-24.2(5). 5

After an investigation, the board reviews the investigation record, discusses

the case, and takes one of several actions:

(1) Close the investigative file without action. The board shall notify the complainant and the licensee of the decision by letter. The board may reconsider and reopen a closed complaint or investigative file at a later date should it be deemed appropriate. (2) Request further investigation, including peer review.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Mark B. Irland, M.D. v. Iowa Board of Medicine, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mark-b-irland-md-v-iowa-board-of-medicine-iowactapp-2019.